CD8A and posterior cortical atrophy: Furthermore, administration of the UBC9 inhibitor 2-D08 alone reactivated the TAM–CD8+ T cell axis and halted PCa progression, while combination of 2-D08 with anti–PD-1 antibody further increased the overall immunotherapeutic effect.